LITH (BioELife) Common Stock: $0.01 Mil (As of Sep. 2019)


What is BioELife Common Stock?

BioELife LITH -99.00% Common Stock is $0.01 Mil as of Sep. 2019.

BioELife's quarterly common stock increased from Mar. 2019 ($0.00 Mil) to Jun. 2019 ($0.01 Mil) but then stayed the same from Jun. 2019 ($0.01 Mil) to Sep. 2019 ($0.01 Mil).

BioELife's annual common stock declined from Dec. 2016 ($0.09 Mil) to Dec. 2017 ($0.00 Mil) but then stayed the same from Dec. 2017 ($0.00 Mil) to Dec. 2018 ($0.00 Mil).

BioELife Common Stock Historical Data

* Premium members only.

The historical data trend for BioELife's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioELife Common Stock Chart

BioELife Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.09 0.09 0.00 0.00

BioELife Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.00 0.00 0.01 0.01

BioELife Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.01 Mil mean?
BioELife (LITH) has a Common Stock of $0.01 Mil as of Sep. 2019. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on BioELife and its competitors.
Is BioELife's Common Stock too high?
BioELife's current Common Stock is $0.01 Mil.
How does BioELife's Common Stock compare to BSPK and PCYN?
BioELife's Common Stock of $0.01 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on BioELife and its competitors. BioELife's current Common Stock is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioELife stock overvalued right now?
BioELife (LITH) has a current Common Stock of $0.01 Mil. The current Common Stock is $0.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For BioELife (LITH), the current Common Stock is $0.01 Mil as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioELife Business Description

Address 12340 Seal Beach Boulevard, Suite B-190, Seal Beach, CA, USA, 90740
BioELife Corp is engaged in the manufacturing and distribution of Cannabinoid products. The company's product portfolio includes Combo Adult Gummies with Chirorub; Combo Tincture with Chirorub; Intensive Relief Rub; Tinctures; Adult Gummies; Premium Pre-Rolls; and Flower.